Ep. 133: Nina Deka: Healthcare Technology Still In Early Stages Of Disruption
Investing With IBD
00:00
Catalin, a Drug Manufacturing Company
Catalin, this is one where it's been on a lot of our screens, because this is one that has had some strong revenue growth. They recently raised their long term a revenue growth rate by a hundred basis points. And what a lot of people don't know about catlin is they invented the soft sell. That bodes very well for a brand new part of the industry.
Transcript
Play full episode
